NASDAQ: ALGN
Align Technology Inc Stock

$171.41+4.23 (+2.53%)
Updated Apr 17, 2025
ALGN Price
$171.41
Fair Value Price
$184.83
Market Cap
$12.62B
52 Week Low
$141.74
52 Week High
$327.49
P/E
30.45x
P/B
3.28x
P/S
3.9x
PEG
1.48x
Dividend Yield
N/A
Revenue
$4.00B
Earnings
$421.36M
Gross Margin
70%
Operating Margin
15.23%
Profit Margin
10.5%
Debt to Equity
0.61
Operating Cash Flow
$738M
Beta
1.6
Next Earnings
Apr 22, 2025
Ex-Dividend
N/A
Next Dividend
N/A

ALGN Overview

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine ALGN's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Device

Industry Rating
C
ALGN
Ranked
#34 of 102

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$7.82A
$22.79A
$13.33A
View Top Medical Device Stocks

Be the first to know about important ALGN news, forecast changes, insider trades & much more!

ALGN News

Overview

Due Diligence Score

Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ALGN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ALGN ($171.41) is undervalued by 7.26% relative to our estimate of its Fair Value price of $184.83 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ALGN ($171.41) is not significantly undervalued (7.26%) relative to our estimate of its Fair Value price of $184.83 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ALGN ($171.41) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ALGN due diligence checks available for Premium users.

Valuation

ALGN fair value

Fair Value of ALGN stock based on Discounted Cash Flow (DCF)

Price
$171.41
Fair Value
$184.83
Undervalued by
7.26%
ALGN ($171.41) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ALGN ($171.41) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ALGN ($171.41) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ALGN price to earnings (PE)

For valuing profitable companies with steady earnings

Company
30.45x
Industry
41.14x
Market
27.98x
ALGN is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ALGN is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

ALGN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
3.28x
Industry
3.8x
ALGN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ALGN price to earnings growth (PEG)

For valuing profitable companies with growth potential

ALGN is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

ALGN's financial health

Profit margin

Revenue
$995.2M
Net Income
$103.8M
Profit Margin
10.4%
ALGN's Earnings (EBIT) of $608.96M... subscribe to Premium to read more.
Interest Coverage Financials
ALGN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$6.2B
Liabilities
$2.4B
Debt to equity
0.61
ALGN's short-term assets ($2.49B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ALGN's short-term assets ($2.49B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ALGN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ALGN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$286.1M
Investing
-$53.9M
Financing
-$203.0M
ALGN's operating cash flow ($738.23M)... subscribe to Premium to read more.
Debt Coverage Financials

ALGN vs Medical Device Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ALGNC$12.62B+2.53%30.45x3.28x
SNNA$11.38B+0.93%27.47x2.16x
PENB$10.68B-0.16%770.42x9.28x
GMEDB$9.77B-0.18%93.43x2.34x
MASIB$8.21B+0.31%-26.60x7.80x

Align Technology Stock FAQ

What is Align Technology's quote symbol?

(NASDAQ: ALGN) Align Technology trades on the NASDAQ under the ticker symbol ALGN. Align Technology stock quotes can also be displayed as NASDAQ: ALGN.

If you're new to stock investing, here's how to buy Align Technology stock.

What is the 52 week high and low for Align Technology (NASDAQ: ALGN)?

(NASDAQ: ALGN) Align Technology's 52-week high was $327.49, and its 52-week low was $141.74. It is currently -47.66% from its 52-week high and 20.93% from its 52-week low.

How much is Align Technology stock worth today?

(NASDAQ: ALGN) Align Technology currently has 73,597,648 outstanding shares. With Align Technology stock trading at $171.41 per share, the total value of Align Technology stock (market capitalization) is $12.62B.

Align Technology stock was originally listed at a price of $16.88 in Jan 30, 2001. If you had invested in Align Technology stock at $16.88, your return over the last 24 years would have been 915.76%, for an annualized return of 10.14% (not including any dividends or dividend reinvestments).

How much is Align Technology's stock price per share?

(NASDAQ: ALGN) Align Technology stock price per share is $171.41 today (as of Apr 17, 2025).

What is Align Technology's Market Cap?

(NASDAQ: ALGN) Align Technology's market cap is $12.62B, as of Apr 20, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Align Technology's market cap is calculated by multiplying ALGN's current stock price of $171.41 by ALGN's total outstanding shares of 73,597,648.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.